Our Take
Medicare ACCESS is real policy with real payer commitments, but the article conflates a reimbursement framework opening with proof that AI health companies can sustain profitability inside it—that race is still running.
Why it matters
Over 200 million Americans will operate under outcome-based reimbursement within 24 months, forcing a structural shift away from visit volume. Digital health companies with low-cost AI infrastructure are positioned to thrive; traditional providers and high-overhead startups face margin compression.
Do this week
Healthcare founders: map your cost-to-serve per patient across AI vs. human coaching; if you can't achieve profitability at Medicare rates (roughly 33% of commercial), the ACCESS model is not your market.
Medicare ACCESS Opens Outcome-Based Reimbursement to 200M Americans
In December 2025, Centers for Medicare & Medicaid Services (CMS) launched the ACCESS Model, a value-based care framework that pays providers based on clinical outcomes rather than billable minutes. The model asks: Is the patient's A1c controlled? Is blood pressure managed? Not: how many visits occurred.
The uptake is accelerating. The Medicare ACCESS Payer Pledge has committed 165 million lives across commercial payers to adopt the outcomes-based billing infrastructure by 2028 (per the author's account). Combined with Medicare's direct enrollment, more than 200 million Americans will operate under this reimbursement structure within two years.
The approved providers list, published weeks after the policy launch, reveals a stark pattern: few large health systems qualified; many prominent digital health companies were absent. Those that did qualify tend to operate with AI-driven care models that don't scale linearly with staff headcount.
The Math Only Works for Companies That Can Operate at Low Cost Per Patient
Medicare reimbursement rates are conservative. Commercial payers typically pay up to 300% of Medicare rates for identical clinical activities (per the author). ACCESS compounds the pressure by conditioning all payment on outcomes, not effort. For providers relying on call centers, nurses, or heavily staffed clinician networks, the economics don't survive.
Organizations with AI-first care delivery (digital coaching, automated monitoring, escalation to live clinicians only when necessary) face a different equation. Their cost-to-serve doesn't scale linearly with patient volume. An AI health coach can interact with millions 24/7 on a mobile app; hiring another nurse cannot. This structural advantage makes the ACCESS reimbursement rates sustainable for some and fatal for others.
The policy also signals a regulatory bet: as cost pressure intensifies across 200 million lives, safety and compliance in AI systems will become table stakes. The author predicts a race to publish peer-reviewed clinical evidence, pass AI audits from national PBMs and health plans, and obtain regulatory certifications. Hallucinations and patient privacy failures will be the downside risk if oversight lags.
Audit Your Unit Economics Against Medicare ACCESS Rates Now
If your healthcare business model assumes commercial payer rates or relies on high clinician-to-patient ratios, Medicare ACCESS forces a reckoning. Calculate your cost-to-serve at one-third of current reimbursement. If profitability is marginal or negative, the 200-million-life migration over 24 months will compress your margins faster than you can cut costs.
If you have built AI-driven care infrastructure with proven clinical outcomes (ideally peer-reviewed), audit your readiness to participate in ACCESS provider networks. The regulatory window is open, but competition for approved provider slots will intensify as payers commit to the framework.
For investors in healthtech: distinguish between companies optimizing for fee-for-service margin and those architected for outcome-based efficiency. The policy creates a structural bifurcation. One cohort will become legacy; the other will scale.